Explore comprehensive CDMO, CMO and CRO services offered by Chartwell Pharmaceuticals, supporting end-to-end Anlaytical Testing, Clinical Studies, Drug Development, Manufacturing and Packaging. Chartwell Pharmaceuticals enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: U.S.A
Description: Chartwell Pharmaceuticals operates four major manufacturing and analytical campuses in the New York metropolitan area, specializing in the production of high-quality generic prescription pharmaceuticals. Their product offerings span a wide range of dosage forms, including tablets, capsules, powders, solutions and suspensions, semi-solids, ophthalmics, otics, and — in the near future — injectable formulations. These products are delivered in both traditional and custom packaging solutions. With decades of experience in the pharmaceutical industry, Chartwell Pharmaceuticals supports every phase of the product lifecycle, from formulation trials and clinical supplies to full-scale commercial manufacturing — for both small and large batch sizes. The company is recognized for its ability to deliver reliably and on schedule. Operating in a highly regulated and complex industry environment, Chartwell maintains pristine, fully cGMP-compliant facilities and employs some of the most advanced technologies available in pharmaceutical manufacturing. The organization continues to invest in expanding and upgrading its capabilities to meet the growing demand for high-quality, domestically produced pharmaceuticals. Chartwell's commitment to quality and regulatory compliance is reflected in its portfolio, which includes over 1,100 FDA-approved Orange Book listings. Many of its products are Trade Agreements Act (TAA) and Buy American Act (BAA) compliant and are marketed under the Chartwell RX label. - Show More
